Glycemic control by a glucose management service and infection rates after liver transplantation

Endocrine Practice

Volumn 17, Issue 4, 2011, Pages 546-551

  Wallia, Amisha ^a   Parikh, Neehar D ^a   O'Shea Mahler, Eileen ^a   Schmidt, Kathleen ^a   Desantis, Anthony J ^b   Tian, Lu ^c   Levitsky, Josh ^a   Molitch, Mark E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTIFICIAL VENTILATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE MANAGEMENT SERVICE; GLYCEMIC CONTROL; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITAL READMISSION; HUMAN; INFECTION RATE; INSULIN INFUSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; REVIEW;

EID: 84860389103     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10343.OR     Document Type: Review

References (16)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
2. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract. 2006;12:491-505. (Pubitemid 46456036)
3. Ganji MR, Charkhchian M, Hakemi M, et al. Association of hyperglycemia on allograft function in the early period after renal transplantation. Transplant Proc. 2007;39:852-854. (Pubitemid 46764872)
4. Hosseini MS, Nemati E, Pourfarziani V, Taheri S, Nourbala MH, Einollahi B. Early hyperglycemia after allogenic kidney transplantation: does it induce infections? Ann Transplant. 2007;12:23-26.
5. Wallia A, Parikh ND, Molitch ME, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation. 2010;89:222-226.
6. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871. (Pubitemid 30169932)
7. Schnipper JL, Liang CL, Ndumele CD, Pendergrass ML. Effects of a computerized order set on the inpatient management of hyperglycemia: a cluster-randomized controlled trial. Endocr Pract. 2010;16:209-218.
8. Finfer S, Chittock DR, Su SY, et al (NICE-SUGAR Study Investigators). Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360:1283-1297.
9. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821-827.
10. Schmeltz LR, DeSantis AJ, Thiyagarajan V, et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care. 2007;30:823-828. (Pubitemid 46556574)
11. Thomas MC, Moran J, Mathew TH, Russ GR, Rao MM. Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes. BMC Nephrol. 2000;1:1.
12. Ammori JB, Sigakis M, Englesbe MJ, O'Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res. 2007;140:227-233. (Pubitemid 46726378)
13. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM Jr, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit [with discussion]. Am Surg. 2008;74:679-685.
14. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006; 105:244-252. (Pubitemid 44148168)
15. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008-3013.
16. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006;12:641-650.